Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809367 · ClinicalTrials.gov registry record · NA
Collection and Banking of Leukemia Cells MDS/AML
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00809367 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 90 participants.
The verdict
NCT00809367, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The goal of this research study is to determine if it is feasible to collect leukemia cells from patients ahead of time (before they undergo further treatments) so that these cells (after being radiated so they will no longer grow or divide) can be given back to them as a cancer vaccine if/after the participant receives a bone marrow or blood stem cell transplant in the future. The purpose of the research study will be to collect, freeze and store leukemia calls from participants blood or bone marrow. This study is a companion study to a vaccine study.
Interventions
- OTHER Collection of Leukemia Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00809367
The ClinicalTrials.gov registry entry for NCT00809367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collection of Leukemia Cells is the first listed.
NCT00809367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00809367 about?
NCT00809367 is a clinical study titled "Collection and Banking of Leukemia Cells MDS/AML". The goal of this research study is to determine if it is feasible to collect leukemia cells from patients ahead of time (before they undergo further treatments) so that these cells (after being radiated so they will no longer grow or divide) can be given back to them as a cancer vaccine if/after the...
What is the current status of trial NCT00809367?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2008-10. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00809367?
The interventions under investigation include: Collection of Leukemia Cells (OTHER).
Who is sponsoring clinical trial NCT00809367?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.